Literature DB >> 16868735

[Diagnosis and immunohistochemistry of medullary breast cancer].

S Milde1, J Gaedcke, R v Wasielewski, H Bruchardt, L Wingen, D Gadzicki, H Arps, H H Kreipe.   

Abstract

Medullary carcinoma of the breast has a relatively favorable prognosis despite its malignant histopathological appearance, providing a challenge for the pathologically based diagnosis of breast cancer. Macroscopic and microscopic findings combined provide diagnostic criteria. The importance of the immunophenotype of medullary carcinoma is not well defined. Because the reproducibility of morphological criteria is limited, we conducted an immunohistochemical study in search of markers that could facilitate histopathological classification. We examined 32 medullary carcinomas in comparison with 30 high grade ductal invasive carcinomas with similar morphology using 23 different immunohistochemical markers. The results showed an overlap with the so called basal like subtype of invasive breast cancer (negativity for steroid hormone receptor, positivity for basal cytokeratins). None of the immunohistochemical markers enabled a specific discrimination between the two groups. Medullary carcinomas overexpress EGF-R more frequently (P<0.004). In combining the characteristic morphological criteria and the immunohistochemical detection of the basal like phenotype and EGFR, a higher diagnostic accuracy can be achieved. The immunophenotype alone does not allow a definite classification of medullary carcinoma.

Entities:  

Mesh:

Year:  2006        PMID: 16868735     DOI: 10.1007/s00292-006-0850-1

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  10 in total

1.  Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up.

Authors:  R L Ridolfi; P P Rosen; A Port; D Kinne; V Miké
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

2.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.

Authors:  T Sørlie; C M Perou; R Tibshirani; T Aas; S Geisler; H Johnsen; T Hastie; M B Eisen; M van de Rijn; S S Jeffrey; T Thorsen; H Quist; J C Matese; P O Brown; D Botstein; P E Lønning; A L Børresen-Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

3.  Typical medullary breast carcinomas have a basal/myoepithelial phenotype.

Authors:  Jocelyne Jacquemier; Laetitia Padovani; Laetitia Rabayrol; Sunil R Lakhani; Frédérique Penault-Llorca; Yves Denoux; Maryse Fiche; Paulo Figueiro; Véronique Maisongrosse; Viviane Ledoussal; Jose Martinez Penuela; Nora Udvarhely; George El Makdissi; Christophe Ginestier; Jeannine Geneix; Emmanuelle Charafe-Jauffret; Luc Xerri; François Eisinger; Daniel Birnbaum; Hagay Sobol
Journal:  J Pathol       Date:  2005-11       Impact factor: 7.996

4.  Medullary carcinoma of the breast: a clinicopathologic study with appraisal of current diagnostic criteria.

Authors:  E S Wargotz; S G Silverberg
Journal:  Hum Pathol       Date:  1988-11       Impact factor: 3.466

5.  Inter- and intraobserver variability in the histopathological diagnosis of medullary carcinoma of the breast, and its prognostic implications.

Authors:  L Pedersen; S Holck; T Schiødt; K Zedeler; H T Mouridsen
Journal:  Breast Cancer Res Treat       Date:  1989-10       Impact factor: 4.872

6.  Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma.

Authors:  William F Anderson; Kenneth C Chu; Shine Chang; Mark E Sherman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-07       Impact factor: 4.254

7.  Medullary carcinoma of the breast. A multicenter study of its diagnostic consistency.

Authors:  C Rigaud; S Theobald; P Noël; J Badreddine; C Barlier; A Delobelle; A Gentile; J Jacquemier; V Maisongrosse; M Peffault de Latour
Journal:  Arch Pathol Lab Med       Date:  1993-10       Impact factor: 5.534

8.  Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years.

Authors:  H J Bloom; W W Richardson; J R Field
Journal:  Br Med J       Date:  1970-07-25

9.  Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma.

Authors:  V Rapin; G Contesso; H Mouriesse; F Bertin; M J Lacombe; J D Piekarski; J P Travagli; C Gadenne; S Friedman
Journal:  Cancer       Date:  1988-06-15       Impact factor: 6.860

10.  Typical medullary carcinoma of the breast: a clinical and pathological analysis of 52 cases.

Authors:  M Reinfuss; A Stelmach; J Mitus; J Rys; K Duda
Journal:  J Surg Oncol       Date:  1995-10       Impact factor: 3.454

  10 in total
  1 in total

1.  Expression of MAGE-A and NY-ESO-1 cancer/testis antigens in medullary breast cancer: retrospective immunohistochemical study.

Authors:  Bozica Matković; Antonio Juretić; Giulio C Spagnoli; Viktor Separović; Marija Gamulin; Robert Separović; Nera Sarić; Martina Basić-Koretić; Irena Novosel; Bozo Kruslin
Journal:  Croat Med J       Date:  2011-04-15       Impact factor: 1.351

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.